LifeStance CPO has 8,156 shares withheld for taxes

Rhea-AI Filing Summary

LifeStance Health Group, Inc. (LFST) reported that Chief People Officer Ann Varanakis had 8,156 shares of common stock withheld on August 24, 2026 to satisfy tax withholding obligations upon vesting of restricted stock units. The shares were valued at $12.16 per share and were not sold in the open market, leaving her with 413,881 shares held directly after the transaction.

Insider Trade Summary

Net Seller: 8,156 shares

Net Sell 1 txn

Insider Varanakis Ann

Role Chief People Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	8,156	$12.16	$99K

Holdings After Transaction: Common Stock — 413,881 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on August 24, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

Key Figures

Shares withheld for tax: 8,156 shares Per-share value for withholding: $12.16 per share Shares held after transaction: 413,881 shares

3 metrics

Shares withheld for tax 8,156 shares Shares withheld on August 24, 2026 to satisfy tax withholding obligations on vested RSUs

Per-share value for withholding $12.16 per share Value applied to the 8,156 shares withheld for tax obligations

Shares held after transaction 413,881 shares Directly held by Ann Varanakis following the August 24, 2026 transaction

Key Terms

restricted stock units, net settlement, tax withholding obligations

3 terms

restricted stock units financial

"in connection with the net settlement of restricted stock units ("RSUs") that vested"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

net settlement financial

"in connection with the net settlement of restricted stock units ("RSUs")"

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection"

FAQ

What insider transaction did LFST disclose for Ann Varanakis on August 24, 2026?

LFST disclosed that 8,156 shares of common stock were withheld from Chief People Officer Ann Varanakis on August 24, 2026 to cover tax withholding obligations related to vested RSUs, at a value of $12.16 per share, with no open-market sale involved.

Did Ann Varanakis sell LifeStance Health Group (LFST) shares in the market?

No. The filing states the 8,156 shares represented shares withheld by the issuer to satisfy tax withholding on vested RSUs and "do not constitute any open-market sale."

How many LFST shares does Ann Varanakis hold after this transaction?

After the tax-withholding transaction, Ann Varanakis directly holds 413,881 shares of LifeStance Health Group, Inc. common stock, as reported in the Form 4.

What was the price used for the LFST tax-withholding shares?

The shares withheld to satisfy tax obligations were valued at $12.16 per share, according to the Form 4 transaction details.

What triggered the LFST share withholding for Ann Varanakis?

The withholding of 8,156 shares was triggered by the net settlement of RSUs that vested on August 24, 2026, with the issuer retaining shares to cover related tax withholding obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 05:17 PM Accepted by SEC EDGAR 08/26/2026 - 05:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Varanakis Ann

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/24/2026		F(1)		8,156	D	$12.16	413,881	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on August 24, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

	By: /s/ Ryan Pardo, Attorney-in-Fact	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)